Evidence map›Paper›PMID 35052960›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Ceftriaxone for the Treatment of Chronic Bacterial Prostatitis: A Case Series and Literature Review.

Sander G Kuiper, Maarten Ploeger, Erik B Wilms, Marleen M van Dijk, Emiel Leegwater, Robert A G Huis In't Veld, Cees van Nieuwkoop

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sander G KuiperDepartment of Internal Medicine, Haga Teaching Hospital, 2545 AA The Hague, The Netherlands.ORCID 0000-0002-8426-2221
Maarten PloegerDepartment of Hospital Pharmacy, Haga Teaching Hospital, 2545 AA The Hague, The Netherlands.
Erik B WilmsDepartment of Hospital Pharmacy, Haga Teaching Hospital, 2545 AA The Hague, The Netherlands.
Marleen M van DijkDepartment of Urology, Haga Teaching Hospital, 2545 AA The Hague, The Netherlands.
Emiel LeegwaterDepartment of Hospital Pharmacy, Haga Teaching Hospital, 2545 AA The Hague, The Netherlands.
Robert A G Huis In't VeldDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
Cees van NieuwkoopDepartment of Internal Medicine, Haga Teaching Hospital, 2545 AA The Hague, The Netherlands.ORCID 0000-0003-0734-0844
Haga Hospital · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic bacterial prostatitis is increasingly difficult to treat due to rising antimicrobial resistance limiting oral treatment options. In this case series, 11 men with CBP (including patients with urological comorbidities) due to multi-resistant

Indexed as

ceftriaxonechronic bacterial prostatitisEscherichia coli

Identifiers

PMID35052960
PMCPMC8772798
OpenAlexW4205530726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.